Loading…
ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials
In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle...
Saved in:
Published in: | Computers in biology and medicine 2019-08, Vol.111, p.103339-103339, Article 103339 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03 |
---|---|
cites | cdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03 |
container_end_page | 103339 |
container_issue | |
container_start_page | 103339 |
container_title | Computers in biology and medicine |
container_volume | 111 |
creator | Grafféo, Nathalie Latouche, Aurélien Le Tourneau, Christophe Chevret, Sylvie |
description | In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01.
•Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01. |
doi_str_mv | 10.1016/j.compbiomed.2019.103339 |
format | article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02349298v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0010482519302082</els_id><sourcerecordid>2280421650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhi0EomnhLyBLXOCQ4O_Y3NIKKFIkJARny-vYicPGXmwnUfn1eLstSFw4jT3zzDsevwBAjBYYYfFuv7DpMHQhHdxmQRBWLU0pVU_ADMulmiNO2VMwQwijOZOEX4DLUvYIIYYoeg4uKGaMLAWZgV9hsOdyDtXu3sNVhF_hYOwPs3XQpwxDPLlcHBxy6kwX-lDvYPLQulhSDnELzy5sd_X-FOoOmgjNMPTBmhpShDXBSdqVJgVtH2Ir9bDmYPryAjzzLbiXD_EKfP_44dvN7Xz95dPnm9V6btsWdU47oZjnSJmOScMJVhwRb4zyzCthKLPYSSeWXAqJPObUSm486TadaLcO0SvwdtLdmV4PORxMvtPJBH27Wusxhwhliih5wo19M7Ft459HV6o-hGJd35vo0rFoQiTFiAshGvr6H3Sfjjm2TUYKMYIFH4fLibI5lZKd__MCjPTopd7rv17q0Us9edlaXz0MOHZj7bHx0bwGXE-Aa793Ci7rYoOL1m1CdrbqTQr_n_IbCo-02Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2280421650</pqid></control><display><type>article</type><title>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</title><source>ScienceDirect Journals</source><creator>Grafféo, Nathalie ; Latouche, Aurélien ; Le Tourneau, Christophe ; Chevret, Sylvie</creator><creatorcontrib>Grafféo, Nathalie ; Latouche, Aurélien ; Le Tourneau, Christophe ; Chevret, Sylvie</creatorcontrib><description>In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01.
•Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01.</description><identifier>ISSN: 0010-4825</identifier><identifier>EISSN: 1879-0534</identifier><identifier>DOI: 10.1016/j.compbiomed.2019.103339</identifier><identifier>PMID: 31442762</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Applications ; Bias ; Clinical trials ; Constitution ; Inverse probability weighting ; Methods ; Patients ; Randomization ; Randomized clinical trial ; Statistics ; Survival ; Survival analysis ; Switches ; Time dependence ; Treatment switch ; Tumors ; Weighting</subject><ispartof>Computers in biology and medicine, 2019-08, Vol.111, p.103339-103339, Article 103339</ispartof><rights>2019 Elsevier Ltd</rights><rights>Copyright © 2019 Elsevier Ltd. All rights reserved.</rights><rights>2019. Elsevier Ltd</rights><rights>Attribution - NonCommercial</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</citedby><cites>FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</cites><orcidid>0000-0001-7227-7525 ; 0000-0001-9218-0333</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31442762$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://cnam.hal.science/hal-02349298$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Grafféo, Nathalie</creatorcontrib><creatorcontrib>Latouche, Aurélien</creatorcontrib><creatorcontrib>Le Tourneau, Christophe</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><title>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</title><title>Computers in biology and medicine</title><addtitle>Comput Biol Med</addtitle><description>In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01.
•Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01.</description><subject>Applications</subject><subject>Bias</subject><subject>Clinical trials</subject><subject>Constitution</subject><subject>Inverse probability weighting</subject><subject>Methods</subject><subject>Patients</subject><subject>Randomization</subject><subject>Randomized clinical trial</subject><subject>Statistics</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Switches</subject><subject>Time dependence</subject><subject>Treatment switch</subject><subject>Tumors</subject><subject>Weighting</subject><issn>0010-4825</issn><issn>1879-0534</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNqFkU1vEzEQhi0EomnhLyBLXOCQ4O_Y3NIKKFIkJARny-vYicPGXmwnUfn1eLstSFw4jT3zzDsevwBAjBYYYfFuv7DpMHQhHdxmQRBWLU0pVU_ADMulmiNO2VMwQwijOZOEX4DLUvYIIYYoeg4uKGaMLAWZgV9hsOdyDtXu3sNVhF_hYOwPs3XQpwxDPLlcHBxy6kwX-lDvYPLQulhSDnELzy5sd_X-FOoOmgjNMPTBmhpShDXBSdqVJgVtH2Ir9bDmYPryAjzzLbiXD_EKfP_44dvN7Xz95dPnm9V6btsWdU47oZjnSJmOScMJVhwRb4zyzCthKLPYSSeWXAqJPObUSm486TadaLcO0SvwdtLdmV4PORxMvtPJBH27Wusxhwhliih5wo19M7Ft459HV6o-hGJd35vo0rFoQiTFiAshGvr6H3Sfjjm2TUYKMYIFH4fLibI5lZKd__MCjPTopd7rv17q0Us9edlaXz0MOHZj7bHx0bwGXE-Aa793Ci7rYoOL1m1CdrbqTQr_n_IbCo-02Q</recordid><startdate>20190801</startdate><enddate>20190801</enddate><creator>Grafféo, Nathalie</creator><creator>Latouche, Aurélien</creator><creator>Le Tourneau, Christophe</creator><creator>Chevret, Sylvie</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><general>Elsevier</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AL</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0N</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><orcidid>https://orcid.org/0000-0001-7227-7525</orcidid><orcidid>https://orcid.org/0000-0001-9218-0333</orcidid></search><sort><creationdate>20190801</creationdate><title>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</title><author>Grafféo, Nathalie ; Latouche, Aurélien ; Le Tourneau, Christophe ; Chevret, Sylvie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Applications</topic><topic>Bias</topic><topic>Clinical trials</topic><topic>Constitution</topic><topic>Inverse probability weighting</topic><topic>Methods</topic><topic>Patients</topic><topic>Randomization</topic><topic>Randomized clinical trial</topic><topic>Statistics</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Switches</topic><topic>Time dependence</topic><topic>Treatment switch</topic><topic>Tumors</topic><topic>Weighting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Grafféo, Nathalie</creatorcontrib><creatorcontrib>Latouche, Aurélien</creatorcontrib><creatorcontrib>Le Tourneau, Christophe</creatorcontrib><creatorcontrib>Chevret, Sylvie</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Computing Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Computing Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Computers in biology and medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Grafféo, Nathalie</au><au>Latouche, Aurélien</au><au>Le Tourneau, Christophe</au><au>Chevret, Sylvie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials</atitle><jtitle>Computers in biology and medicine</jtitle><addtitle>Comput Biol Med</addtitle><date>2019-08-01</date><risdate>2019</risdate><volume>111</volume><spage>103339</spage><epage>103339</epage><pages>103339-103339</pages><artnum>103339</artnum><issn>0010-4825</issn><eissn>1879-0534</eissn><abstract>In randomized clinical trials (RCT), the analysis is based on the intent-to-treat principle to avoid any selection bias in the constitution of groups. However, estimates of overall survival can be biased when significant crossover occurs because the separation of randomized groups is lost. To handle these switches, the inverse probability of censoring weighting (IPCW) method has been proposed; however, it is still poorly used in RCT, notably because of its complex implementation. In particular, for time-to-event outcomes, it can be difficult to format data, especially when time-dependent covariates have to be managed, with different measurement times between patients. This paper aims to present the R package ipcwswitch with some guidance for the analysis of the treatment effect on survival in a hypothetical setting where all patients would have continued to take the randomization treatment. After a brief recall of the key principles of the IPCW method, each step of the implementation is described using a toy example. The guidelines are illustrated in a case study that aimed at evaluating the benefit of therapy based on tumour molecular profiling for advanced cancers, SHIVA01.
•Handling treatment switches in the randomized clinical trial setting.•R package implementing the inverse probability of censoring weights (IPCW) method.•New R functions to facilitate data formatting.•Step-by-step tutorial to run the IPCW method.•Focus on a previously published randomized clinical trial, SHIVA01.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>31442762</pmid><doi>10.1016/j.compbiomed.2019.103339</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-7227-7525</orcidid><orcidid>https://orcid.org/0000-0001-9218-0333</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0010-4825 |
ispartof | Computers in biology and medicine, 2019-08, Vol.111, p.103339-103339, Article 103339 |
issn | 0010-4825 1879-0534 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_02349298v1 |
source | ScienceDirect Journals |
subjects | Applications Bias Clinical trials Constitution Inverse probability weighting Methods Patients Randomization Randomized clinical trial Statistics Survival Survival analysis Switches Time dependence Treatment switch Tumors Weighting |
title | ipcwswitch: An R package for inverse probability of censoring weighting with an application to switches in clinical trials |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A13%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ipcwswitch:%20An%20R%20package%20for%20inverse%20probability%20of%20censoring%20weighting%20with%20an%20application%20to%20switches%20in%20clinical%20trials&rft.jtitle=Computers%20in%20biology%20and%20medicine&rft.au=Graff%C3%A9o,%20Nathalie&rft.date=2019-08-01&rft.volume=111&rft.spage=103339&rft.epage=103339&rft.pages=103339-103339&rft.artnum=103339&rft.issn=0010-4825&rft.eissn=1879-0534&rft_id=info:doi/10.1016/j.compbiomed.2019.103339&rft_dat=%3Cproquest_hal_p%3E2280421650%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c534t-3b694f509ab48a5219502faa9f4f96a34c1e8e6758680f153c85af2bdb6f15b03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2280421650&rft_id=info:pmid/31442762&rfr_iscdi=true |